Table 1.
Diagnoses of patients with a major depressive episode (n = 25).
Table 2.
Psychotropic drug treatment for patients with major depression (n = 25).
Table 3.
Psychotropic drug treatment for patients with schizophrenia (n = 24).
Figure 1.
Mean activity from Table 4.
*p<0.05, **p<0.01 compared to control group.
Figure 2.
Standard deviation from Table 4.
# p<0.05 depression compared to schizophrenia.
Figure 3.
Root mean square successive differences from Table 4.
Figure 4.
RMSSD/SD from Table 4.
*** p<0.001; schizophrenia compared to the control group. ## p<0.01; depression compared to schizophrenia.
Figure 5.
Sample entropy from Table 4.
## p<0.01; depression compared to schizophrenia.
Figure 6.
Activity from Table 5.
*** p<0.001; schizophrenia and depression compared to the control group.
Figure 7.
Standard deviation from Table 5.
*** p<0.001; depression compared to the control group. # p<0.05 depression compared to schizophrenia.
Figure 8.
Root mean square successive differences from Table 5.
# p<0.05 depression compared to schizophrenia.
Figure 9.
RMSSD/SD from Table 5.
**p<0.01 schizophrenia compared to control group.
Figure 10.
Sample entropy from Table 5.
Figure 11.
Fourier analysis from Table 5.
*p<0.05, depression compared to control group.
Table 4.
Results from actigraphic recording of 300 min periods with continuous motor activity.
Table 5.
Results from actigraphic recordings for 2 weeks.
Figure 12.
Actigraph recordings of 256 min periods.
Activity counts and Fourier analysis from a control person (A and B) and a patient with schizophrenia (C and D).
Table 6.
Fourier analysis of the actigraphic recording of 300 min periods with continuous motor activity.
Figure 13.
Actigraph recordings of 256 h periods.
Activity counts and Fourier analysis from a control person (A and B) and a patient with depression (C and D).
Table 7.
Correlations between sample entropy (2, 0.2) and various measures of variance.